A detailed history of Summit Trail Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 6,438 shares of AZN stock, worth $502,099. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,438
Previous 7,038 8.53%
Holding current value
$502,099
Previous $474,000 8.02%
% of portfolio
0.01%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$61.03 - $69.57 $36,618 - $41,741
-600 Reduced 8.53%
6,438 $436,000
Q4 2023

Feb 06, 2024

BUY
$61.89 - $69.28 $16,895 - $18,913
273 Added 4.04%
7,038 $474,000
Q3 2023

Oct 30, 2023

SELL
$64.85 - $71.7 $211,864 - $234,243
-3,267 Reduced 32.57%
6,765 $458,000
Q2 2023

Jul 25, 2023

BUY
$69.91 - $75.81 $344,726 - $373,819
4,931 Added 96.67%
10,032 $717,000
Q1 2023

May 04, 2023

BUY
$63.15 - $71.6 $322,128 - $365,231
5,101 New
5,101 $354,000
Q2 2022

Aug 09, 2022

SELL
$59.26 - $71.14 $213,691 - $256,530
-3,606 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $50,816 - $61,213
-912 Reduced 20.19%
3,606 $239,000
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $49,698 - $58,723
920 Added 25.57%
4,518 $263,000
Q3 2021

Nov 16, 2021

BUY
$55.56 - $60.79 $199,904 - $218,722
3,598 New
3,598 $216,000
Q4 2018

Feb 13, 2019

SELL
$36.86 - $41.49 $173,168 - $194,920
-4,698 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$34.76 - $39.72 $163,302 - $186,604
4,698 New
4,698 $186,000
Q2 2018

Aug 10, 2018

SELL
$34.55 - $37.05 $611,224 - $655,451
-17,691 Closed
0 $0
Q1 2018

May 22, 2018

SELL
$32.97 - $36.63 $9.37 Million - $10.4 Million
-284,302 Reduced 94.14%
17,691 $302,000
Q1 2018

May 21, 2018

BUY
$32.97 - $36.63 $9.42 Million - $10.5 Million
285,673 Added 1750.45%
301,993 $302,000
Q4 2017

Feb 14, 2018

BUY
$32.09 - $34.78 $523,708 - $567,609
16,320
16,320 $578,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $242B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.